1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Blue Earth Diagnostics

Anonymous board for Blue Earth Diagnostics

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    2
    Views:
    733
  2. anonymous
    Replies:
    1
    Views:
    1,612
  3. anonymous
    Replies:
    1
    Views:
    1,586
  4. anonymous
    Replies:
    4
    Views:
    4,568

Thread Display Options

Loading...